MAIL ceased publication at the end of 2007.
The information previously published in MAIL is now available in the Medicines regulatory news section on the MHRA website:
›
Medicines regulatory news
Editions of 'MAIL' issued from 2000 onwards are available here. Copies of 'MAIL' not available here can be obtained from the MHRA Information Centre, 10-2, Market Towers, 1 Nine Elms Lane, Vauxhall, London SW8 5NQ, telephone 020 7084 2352, fax 020 7084 2353.
Latest MAIL
-
18 Dec 2007 | MAIL 164
This, the final issue of our updating journal for medicines, includes articles on the Paediatric Regulation, Risk Management Plans, and guidance on the submission of Decentralised and Centralised Procedure applications.
-
18 Oct 2007 | MAIL 163
This issue of our updating journal for medicines includes: compliance with new legal requirements for patient information leaflets; an update on Periodic Safety Update Reports (PSUR) applications; the Pharmacovigilance Service Desk providing a service to marketing authorisation (MA) holders; and the Regulatory Information Service.
-
24 Jul 2007 | MAIL 162
This issue of our updating journal for medicines includes: best practice guidance on the processing of national marketing authorisations; compliance with the new legal requirements for patient information leaflets; and a request for notification of inspections performed in the UK by overseas Inspectorates.
-
30 May 2007 | MAIL 161
This issue of our updating journal for medicines includes clarification of the fee applicable for product licence applications and variations which are electronic Common Technical Document (eCTD) compliant.
-
20 Apr 2007 | MAIL 160
This issue of our updating journal for medicines includes articles on: the proposals for MHRA fees (implemented on 1 April 2007); when risk management plans are required; and guidance for notification of serious breaches of Good Clinical Practice (GCP) or the trial protocol.
-
06 Feb 2007 | MAIL 159
This issue of our updating journal for medicines includes an article on disruptions to the supply of medicines and interpretation of the 'Sunset Clause', and information on requesting the MHRA to act as Reference Member State (RMS) in decentralised procedures.
-
24 Nov 2006 | MAIL 158
This issue of our updating journal for medicines includes a reminder about our Regulatory Information Service and an article on the provision of scientific advice for risk management planning.
-
23 Nov 2006 | Special Mail 5: Guidelines on submission of applications to the MHRA
Special issue of MAIL with FAQs, defining a standard approach to sending submissions to the MHRA.
-
13 Oct 2006 | Special Mail 6: Drugs, Devices and Regulations (DDR '07) Conference and Exhibition
Special Mail 6 highlights our 'Drugs, Devices and Regulations' conference and exhibition to be held in London on 5-6 February 2007.
-
28 Sep 2006 | MAIL 157
This issue of our updating journal for medicines includes articles on updated product information for neuroleptics and new requirements for patient information leaflets.
